{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "84324-031",
      "generic_name": "FEXOFENADINE HYDROCHLORIDE",
      "labeler_name": "NUVICARE LLC",
      "brand_name": "Nuvicare Hives Relief",
      "active_ingredients": [
        {
          "name": "FEXOFENADINE HYDROCHLORIDE",
          "strength": "180 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "84324-031-01",
          "description": "30 TABLET in 1 BOTTLE (84324-031-01)",
          "marketing_start_date": "20260121",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "NUVICARE LLC"
        ],
        "rxcui": [
          "997420"
        ],
        "spl_set_id": [
          "a8e11094-ca69-488d-a720-b8129f17f505"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "2S068B75ZU"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "8a758eab-e855-4cac-85e1-c7df0aa2150d",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20260121",
      "product_id": "84324-031_8a758eab-e855-4cac-85e1-c7df0aa2150d",
      "application_number": "ANDA210137",
      "brand_name_base": "Nuvicare Hives Relief",
      "pharm_class": [
        "Histamine H1 Receptor Antagonists [MoA]",
        "Histamine-1 Receptor Antagonist [EPC]"
      ]
    }
  ]
}